Watchlist Manager

Watchlist

Price: 671 JPY -0.74% Market Closed

Market Cap: ¥19.5B

	Pharma Foods International Co Ltd TSE:2929	JP
S	Shanghai Wanye Enterprises Co Ltd SSE:600641	CN
	Netscientific PLC LSE:NSCI	UK
A	Anxin Trust Co Ltd SSE:600816	CN
G	Gujarat Lease Financing Ltd NSE:GLFL	IN

Income Statement

Currency: JPY

	Apr-2007	Oct-2007	Jan-2008	Apr-2008	Oct-2008	Jan-2009	Apr-2009	Oct-2009	Jan-2010	Apr-2010	Jul-2010	Oct-2010	Jan-2011	Apr-2011	Jul-2011	Oct-2011	Jan-2012	Apr-2012	Jul-2012	Oct-2012	Jan-2013	Apr-2013	Jul-2013	Oct-2013	Jan-2014	Apr-2014	Jul-2014	Oct-2014	Jan-2015	Apr-2015	Jul-2015	Oct-2015	Jan-2016	Apr-2016	Jul-2016	Oct-2016	Jan-2017	Apr-2017	Jul-2017	Oct-2017	Jan-2018	Apr-2018	Jul-2018	Oct-2018	Jan-2019	Apr-2019	Jul-2019	Oct-2019	Jan-2020	Apr-2020	Jul-2020	Oct-2020	Jan-2021	Apr-2021	Jul-2021	Oct-2021	Jan-2022	Apr-2022	Jul-2022	Oct-2022	Jan-2023	Apr-2023	Jul-2023	Oct-2023	Jan-2024	Apr-2024	Jul-2024	Oct-2024	Jan-2025	Apr-2025	Jul-2025	Oct-2025	Jan-2026
Revenue
Interest Expense	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1	1	0	0	0	0	1	2	3	4	4	4	5	5	6	5	5	5	6	6	7	7	7	7	8	8	9	11	11	12	12	19	21	26	42	36	45	48	44	52	55	62	72	76	0	0	0	0
Revenue	648 N/A	686 +6%	655 -5%	613 -6%	629 +3%	642 +2%	562 -12%	555 -1%	608 +10%	682 +12%	959 +41%	934 -3%	911 -2%	940 +3%	1 007 +7%	1 118 +11%	1 156 +3%	1 092 -6%	1 225 +12%	1 289 +5%	1 296 +1%	1 383 +7%	1 525 +10%	1 532 +0%	1 621 +6%	1 591 -2%	1 615 +2%	1 593 -1%	1 734 +9%	1 991 +15%	2 166 +9%	2 490 +15%	3 027 +22%	3 343 +10%	3 461 +4%	3 699 +7%	3 786 +2%	4 336 +15%	4 723 +9%	5 457 +16%	6 388 +17%	7 239 +13%	7 943 +10%	8 905 +12%	9 458 +6%	9 893 +5%	10 533 +6%	11 048 +5%	11 797 +7%	13 777 +17%	15 353 +11%	20 650 +34%	29 294 +42%	37 989 +30%	46 752 +23%	50 971 +9%	55 180 +8%	57 054 +3%	60 185 +5%	64 609 +7%	66 507 +3%	68 668 +3%	68 572 0%	67 684 -1%	65 081 -4%	63 210 -3%	62 147 -2%	60 601 -2%	60 352 0%	61 793 +2%	65 260 +6%	66 376 +2%	83 556 +26%
Gross Profit
Cost of Revenue	(248)	(312)	(370)	(396)	(403)	(399)	(368)	(348)	(345)	(363)	(516)	(509)	(526)	(552)	(589)	(667)	(718)	(668)	(658)	(599)	(561)	(595)	(631)	(661)	(666)	(640)	(712)	(701)	(721)	(796)	(787)	(854)	(990)	(1 013)	(1 002)	(1 005)	(914)	(970)	(1 006)	(1 115)	(1 302)	(1 460)	(1 592)	(1 742)	(1 803)	(1 844)	(1 996)	(2 228)	(2 391)	(2 884)	(3 178)	(3 818)	(4 948)	(5 946)	(7 027)	(7 604)	(9 711)	(10 793)	(12 077)	(13 363)	(13 047)	(13 476)	(13 293)	(13 513)	(13 088)	(12 935)	(13 395)	(12 666)	(12 416)	(12 616)	(12 676)	(13 064)	(16 332)
Gross Profit	399 N/A	373 -7%	284 -24%	218 -23%	226 +4%	242 +7%	194 -20%	206 +6%	263 +27%	319 +21%	443 +39%	424 -4%	385 -9%	389 +1%	417 +7%	451 +8%	438 -3%	424 -3%	567 +34%	690 +22%	736 +7%	789 +7%	894 +13%	871 -3%	955 +10%	950 0%	902 -5%	891 -1%	1 012 +14%	1 195 +18%	1 378 +15%	1 636 +19%	2 037 +25%	2 331 +14%	2 459 +6%	2 693 +10%	2 872 +7%	3 366 +17%	3 716 +10%	4 343 +17%	5 085 +17%	5 779 +14%	6 351 +10%	7 163 +13%	7 654 +7%	8 049 +5%	8 537 +6%	8 819 +3%	9 406 +7%	10 893 +16%	12 175 +12%	16 832 +38%	24 346 +45%	32 043 +32%	39 725 +24%	43 367 +9%	45 469 +5%	46 261 +2%	48 108 +4%	51 246 +7%	53 460 +4%	55 192 +3%	55 279 +0%	54 171 -2%	51 993 -4%	50 275 -3%	48 752 -3%	47 935 -2%	47 936 +0%	49 177 +3%	52 584 +7%	53 312 +1%	67 224 +26%
Operating Income
Operating Expenses	(614)	(617)	(623)	(575)	(500)	(432)	(379)	(385)	(372)	(380)	(507)	(495)	(487)	(477)	(462)	(461)	(462)	(459)	(496)	(525)	(533)	(558)	(676)	(729)	(839)	(977)	(931)	(1 107)	(1 263)	(1 449)	(1 750)	(2 195)	(2 612)	(2 670)	(2 505)	(2 804)	(2 974)	(3 271)	(3 627)	(4 297)	(5 361)	(5 735)	(6 055)	(6 844)	(6 784)	(7 634)	(7 960)	(8 637)	(10 127)	(10 453)	(11 435)	(16 736)	(22 102)	(28 413)	(34 052)	(34 690)	(37 682)	(42 290)	(47 028)	(53 935)	(55 295)	(53 409)	(51 669)	(47 758)	(45 957)	(45 033)	(43 639)	(42 765)	(43 959)	(47 771)	(50 217)	(54 456)	(70 470)
Selling, General & Administrative	(395)	(397)	(408)	(383)	(329)	(282)	(236)	(249)	(241)	(254)	(330)	(328)	(331)	(320)	(317)	(309)	(300)	(295)	(313)	(322)	(341)	(379)	(493)	(540)	(623)	(744)	(719)	(891)	(1 049)	(1 215)	(1 494)	(1 930)	(2 306)	(2 348)	(2 192)	(2 484)	(2 690)	(3 008)	(3 365)	(4 034)	(5 082)	(5 433)	(5 743)	(6 449)	(6 449)	(7 295)	(7 606)	(8 277)	(9 689)	(9 997)	(10 960)	(16 239)	(21 642)	(27 908)	(33 486)	(34 077)	(37 016)	(41 601)	(46 211)	(53 051)	(54 361)	(52 449)	(50 757)	(46 776)	(44 956)	(43 987)	(42 561)	(41 408)	(42 531)	(46 253)	(48 763)	(52 900)	(68 522)
Research & Development	(202)	(202)	(199)	(178)	(156)	(137)	(131)	(124)	(121)	(116)	(164)	(155)	(144)	(146)	(134)	(141)	(152)	(153)	(173)	(193)	(182)	(168)	(172)	(160)	(186)	(204)	(200)	(206)	(203)	(222)	(244)	(252)	(296)	(315)	(313)	(320)	(283)	(252)	(242)	(235)	(240)	(265)	(274)	(288)	(298)	(302)	(317)	(323)	(401)	(419)	(438)	(458)	0	(350)	(522)	(456)	(621)	(643)	(766)	(827)	(869)	(890)	(840)	(911)	(909)	(946)	(978)	(1 038)	(1 134)	(1 233)	(1 399)	(1 394)	(1 784)
Depreciation & Amortization	(18)	(18)	(17)	(15)	(14)	(13)	(13)	(12)	(10)	(9)	(13)	(12)	(12)	(11)	(11)	(11)	(10)	(10)	(10)	(10)	(10)	(11)	(12)	(12)	(12)	(12)	(11)	(11)	(11)	(12)	(12)	(13)	(11)	(7)	0	(1)	(1)	(12)	(20)	(29)	(38)	(36)	(38)	(38)	(38)	(38)	(37)	(37)	(37)	(37)	(37)	(39)	(40)	(42)	(43)	(42)	(42)	(44)	(51)	(58)	(66)	(71)	(72)	(78)	(99)	(99)	(99)	(94)	(69)	(61)	(53)	(43)	(45)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(17)	(17)	(17)	0	0	0	0	0	0	0	0	0	0	0	0	(0)	0	0	0	(0)	(70)	0	(0)	0	0	0	0	(0)	0	(420)	(113)	(1)	(115)	(2)	0	0	1	0	1	0	7	7	(1)	(1)	(225)	(225)	(224)	(2)	(119)	(119)
Operating Income	(215) N/A	(243) -13%	(339) -39%	(358) -6%	(274) +24%	(190) +31%	(186) +2%	(178) +4%	(109) +39%	(61) +45%	(64) -5%	(71) -11%	(103) -45%	(88) +14%	(44) +50%	(10) +77%	(24) -133%	(35) -47%	71 N/A	165 +133%	203 +23%	231 +14%	217 -6%	142 -35%	116 -18%	(26) N/A	(28) -7%	(216) -672%	(250) -16%	(254) -1%	(372) -47%	(560) -50%	(575) -3%	(340) +41%	(46) +86%	(111) -139%	(102) +8%	95 N/A	89 -6%	45 -49%	(275) N/A	45 N/A	296 +563%	319 +7%	870 +173%	415 -52%	576 +39%	183 -68%	(721) N/A	439 N/A	740 +68%	96 -87%	2 244 +2 231%	3 630 +62%	5 673 +56%	8 677 +53%	7 787 -10%	3 971 -49%	1 080 -73%	(2 689) N/A	(1 835) +32%	1 783 N/A	3 610 +102%	6 413 +78%	6 036 -6%	5 242 -13%	5 113 -2%	5 170 +1%	3 977 -23%	1 406 -65%	2 367 +68%	(1 144) N/A	(3 246) -184%
Pre-Tax Income
Interest Income Expense	(2)	(2)	(1)	(1)	(7)	(6)	4	13	17	11	22	12	12	17	20	4	(58)	(53)	(45)	(40)	51	55	80	60	40	27	33	35	40	173	265	266	228	100	(4)	(3)	11	(3)	34	31	36	64	42	38	36	10	3	4	(18)	(19)	(9)	(5)	14	36	26	20	27	22	54	11	(34)	(91)	(109)	(111)	(66)	(56)	(63)	(114)	(146)	(198)	(184)	(125)	(110)
Non-Reccuring Items	(0)	1	(6)	(5)	(11)	(5)	(75)	(71)	(71)	1	1	1	2	(61)	(75)	(75)	(76)	(13)	0	0	0	0	(17)	0	0	0	0	0	(59)	(62)	(115)	(113)	(54)	(52)	2	2	2	2	(30)	(24)	(24)	(24)	(66)	0	(70)	(70)	(1)	(1)	60	60	60	60	(2)	(1)	(1)	81	82	82	82	0	0	8	(42)	0	0	0	(225)	0	0	0	(118)	0	0
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(0)	(0)	0	(0)	0	0	0	0	0	0	0	0	0	0	0	0	0	(16)	(16)	0	0	0	0	0	0	0	32	0	0	0	0	0	0	0	0	0	0	0	77	0	0	71	(6)	0	0	0	0	0	0	0	0	4	(109)
Total Other Income	32	33	30	43	38	38	42	44	48	52	60	72	70	72	57	69	68	50	40	50	46	35	14	24	19	9	7	13	3	33	37	45	70	68	77	57	50	57	46	43	37	34	41	46	89	94	58	78	47	59	58	60	61	64	67	92	106	132	130	222	194	78	89	25	26	6	209	261	306	361	369	171	63
Pre-Tax Income	(184) N/A	(210) -14%	(316) -50%	(322) -2%	(254) +21%	(163) +36%	(215) -32%	(192) +11%	(115) +40%	3 N/A	19 +494%	14 -25%	(19) N/A	(59) -220%	(42) +29%	(12) +72%	(90) -666%	(51) +43%	66 N/A	175 +164%	299 +71%	320 +7%	293 -8%	225 -23%	175 -22%	10 -95%	12 +25%	(168) N/A	(266) -59%	(109) +59%	(184) -70%	(361) -96%	(331) +8%	(223) +33%	29 N/A	(55) N/A	(39) +28%	136 N/A	124 -9%	95 -23%	(227) N/A	119 N/A	314 +164%	402 +28%	925 +130%	448 -52%	669 +49%	263 -61%	(632) N/A	539 N/A	849 +57%	211 -75%	2 316 +997%	3 730 +61%	5 765 +55%	8 870 +54%	8 001 -10%	4 208 -47%	1 423 -66%	(2 456) N/A	(1 675) +32%	1 849 N/A	3 542 +92%	6 327 +79%	5 996 -5%	5 192 -13%	5 034 -3%	5 317 +6%	4 137 -22%	1 569 -62%	2 434 +55%	(1 094) N/A	(3 402) -211%
Net Income
Tax Provision	(3)	(3)	(48)	(12)	(12)	(3)	(3)	(3)	(3)	(3)	(4)	(3)	(3)	(4)	(4)	(5)	(5)	(6)	(6)	(10)	(13)	(14)	(24)	(19)	(15)	(13)	(3)	(3)	(3)	(3)	(3)	(4)	(3)	(4)	(2)	(3)	(5)	(13)	(19)	(23)	(26)	(23)	9	1	(1)	(2)	(161)	(161)	(158)	(161)	(158)	(165)	(536)	(1 291)	(1 924)	(2 370)	(2 152)	(2 205)	(1 797)	(971)	(1 175)	(871)	(462)	(1 139)	(1 233)	(1 323)	(1 828)	(2 037)	(1 469)	(1 343)	(2 066)	(790)	(176)
Income from Continuing Operations	(187)	(213)	(364)	(334)	(266)	(166)	(218)	(195)	(118)	1	15	11	(22)	(63)	(47)	(17)	(96)	(57)	60	165	285	306	269	206	160	(3)	9	(171)	(269)	(112)	(188)	(365)	(334)	(227)	26	(58)	(45)	123	105	73	(253)	96	323	403	925	446	508	102	(790)	378	691	47	1 780	2 439	3 841	6 500	5 849	2 003	(374)	(3 427)	(2 850)	978	3 080	5 188	4 763	3 869	3 206	3 280	2 668	226	368	(1 884)	(3 578)
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	(1)	(0)	(3)	(4)	(3)	(4)	(6)	(7)	(8)	(9)	(12)	(10)	(8)	(8)	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0
Net Income (Common)	(187) N/A	(213) -14%	(364) -70%	(334) +8%	(266) +20%	(166) +38%	(218) -31%	(195) +10%	(118) +40%	1 N/A	15 +2 043%	11 -25%	(22) N/A	(63) -189%	(47) +26%	(17) +65%	(96) -477%	(57) +41%	60 N/A	164 +174%	285 +74%	306 +7%	269 -12%	206 -23%	160 -22%	(3) N/A	9 N/A	(171) N/A	(269) -58%	(112) +58%	(188) -68%	(363) -93%	(332) +8%	(228) +31%	26 N/A	(61) N/A	(49) +20%	120 N/A	101 -16%	67 -34%	(260) N/A	88 N/A	314 +255%	391 +25%	912 +133%	436 -52%	500 +15%	99 -80%	(790) N/A	378 N/A	691 +83%	47 -93%	1 780 +3 728%	2 439 +37%	3 841 +57%	6 499 +69%	5 849 -10%	2 003 -66%	(374) N/A	(3 425) -816%	(2 849) +17%	978 N/A	3 081 +215%	5 187 +68%	4 763 -8%	3 869 -19%	3 205 -17%	3 279 +2%	2 666 -19%	226 -92%	368 +63%	(1 883) N/A	(3 576) -90%
EPS (Diluted)	-7.96 N/A	-9.08 -14%	-15.28 -68%	-14.21 +7%	-11.3 +20%	-6.95 +38%	-9.26 -33%	-8.3 +10%	-4.94 +40%	0.02 N/A	0.62 +3 000%	0.46 -26%	-0.95 N/A	-2.71 -185%	-1.95 +28%	-0.71 +64%	-4.07 -473%	-2.42 +41%	2.5 N/A	6.99 +180%	12.14 +74%	12.95 +7%	11.2 -14%	8.76 -22%	6.8 -22%	-0.11 N/A	0.34 N/A	-5.89 N/A	-9.28 -58%	-3.86 +58%	-6.49 -68%	-12.5 -93%	-11.45 +8%	-7.85 +31%	0.89 N/A	-2.08 N/A	-1.68 +19%	4.14 N/A	3.49 -16%	2.3 -34%	-8.94 N/A	3.04 N/A	10.8 +255%	13.47 +25%	31.41 +133%	14.99 -52%	17.21 +15%	3.42 -80%	-27.21 N/A	13.02 N/A	23.78 +83%	1.6 -93%	61.28 +3 730%	83.77 +37%	132.14 +58%	223.96 +69%	201.77 -10%	68.96 -66%	-12.89 N/A	-118.1 -816%	-98.86 +16%	33.9 N/A	106.7 +215%	179.82 +69%	165.57 -8%	137.77 -17%	112.69 -18%	116.81 +4%	92.07 -21%	7.78 -92%	12.8 +65%	-65.22 N/A	-123.67 -90%

Income Statement Balance Sheet Cash Flow Statement

Pharma Foods International Co Ltd
TSE:2929

Income Statement

Earnings Waterfall
Pharma Foods International Co Ltd

Income Statement
Pharma Foods International Co Ltd

See Also

Company

Help

Tools

Stocks

Pharma Foods International Co Ltd TSE:2929

Income Statement

Earnings Waterfall Pharma Foods International Co Ltd

Income Statement Pharma Foods International Co Ltd

See Also

Company

Help

Tools

Stocks

Pharma Foods International Co Ltd
TSE:2929

Earnings Waterfall
Pharma Foods International Co Ltd

Income Statement
Pharma Foods International Co Ltd